Motley Fool Highlights Biotech Stock as Potential FortuneMaker in Healthcare Sector OTEX Q1 2026 Earnings EPS Surpasses Estimates by 75 as Cloud Momentum Continues Citi Initiates Cytokinetics as Top Pick Among SmalltoMid Cap Biotech Stocks Sees Upside from Myqorzo Launch and Phase 3 Data